InvestorsHub Logo
Followers 0
Posts 5082
Boards Moderated 0
Alias Born 08/26/2012

Re: Robbay post# 309

Tuesday, 10/23/2012 3:33:07 PM

Tuesday, October 23, 2012 3:33:07 PM

Post# of 3163
robb,

My answer on potential revenue loss would depend on how extreme a DEA action might be; if it only precludes oxycontin and oxycodone sales, that is one case. If it precludes all opiate-derivative medications then that is a much more extreme case.

The better outcome would be for Walgreens to settle this mess, pay a fine and get on with life in concert with the DEA initiative and not be in the forward sights of actions going forward.

GLTA,

Yank



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent WBA News